On the 06.11.2015 the official website of Ministry of Health of Ukraine published for public discussion a new draft decree “On approval of the register of patients requiring insulin therapy « (hereinafter - «draft order " and "Patients’ Registrar ").
We would like to recall that Legal Alliance highlighted the main provisions of a similar draft decree, which was published on the website of Ministry of Health of Ukraine in September this year.
In general, the draft decree, like its predecessor, regulates the procedure for providing access to the Patients’ Registrar doctors of health facilities authorized to have information about patients by employees of the Ministry of Health of Ukraine, responsible for the review and analysis of impersonal information, as well as pharmacies, which are entitled to perform supply of medicines on prescriptions with access to the patients registrar.
Another common feature is the establishment of a comprehensive list of information about the patient included in the Patients’ Registrar and the procedure for its formation and maintenance.
In addition, both documents stipulate that the doctor’s prescription is formed via the Patients’ Registrar by adopting a unique number for it which identifies the prescription in the Patients’ Registrar, and then printing and issuing accordance with the rules of advocating prescriptions after which it is issued to the patient. When dispensing insulin on prescription the pharmaceutical institution identifies the prescription via its number and makes a note about the admission of the insulin drug.
Despite considerable similarities the decree drafts have significant differences. According to the Draft Order, the Patient Registry Administrator is the "Center of Electronic Security of the Health Ministry of Ukraine» (hereinafter - «the CESHMU Ukraine "), which was not provided for in the previous draft decree.
Also it is necessary to stress the following differences between these documents:
In general adoption of the Draft Decree is to establish an effective mechanism to ensure the full and fair accounting of insulin, the value of which, we recall, is subject to public reimbursement.
We are thrilled to announce a major milestone in our team's growth and celebrate the well-deserved career advancements of our colleagues.
Lexology Index: Employment & Labor highlights the leading legal specialists in the field from around the world.
On June 19, 2026, an event was held with the participation of businesses, regulators, and experts – titled “Regulatory Dialogue: The Cosmetics Market” – organiz
The event brought together leading industry experts for a comprehensive analysis of the institutional landscape and current legal challenges in the sphere of state-business interaction.